ArticlePloS one2026

Retraction: Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations.

PLOS One EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.